Search filters

List of works by Diana L Castillo-Carranza

Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species.

scientific article

Alzheimer brain-derived tau oligomers propagate pathology from endogenous tau

scientific article published on 3 October 2012

Amyloid-β oligomers as a template for secondary amyloidosis in Alzheimer's disease

scientific article published on 15 August 2014

Antibody against Small Aggregated Peptide Specifically Recognizes Toxic Aβ-42 Oligomers in Alzheimer's Disease

scientific article published on 8 October 2015

Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies

scientific article

Design of metastable β-sheet oligomers from natively unstructured peptide

scientific article published on 14 October 2013

Differential Activation of the ER Stress Factor XBP1 by Oligomeric Assemblies

scientific article published on April 21, 2012

Dual role of p53 amyloid formation in cancer; loss of function and gain of toxicity.

scientific article

Formation of immunoglobulin light chain amyloid oligomers in primary cutaneous nodular amyloidosis.

scientific article published on 17 October 2011

Identification of oligomers at early stages of tau aggregation in Alzheimer's disease

scientific article published on January 17, 2012

Passive immunization with Tau oligomer monoclonal antibody reverses tauopathy phenotypes without affecting hyperphosphorylated neurofibrillary tangles.

scientific article published in March 2014

Pathological interface between oligomeric alpha-synuclein and tau in synucleinopathies

scientific article

Pitx3 promoter directs Cre-recombinase specifically in a human neuroblastoma cell line.

scientific article published on 30 November 2007

Preparation and Characterization of Neurotoxic Tau Oligomers

scientific article published on November 8, 2010

Rapid accumulation of endogenous tau oligomers in a rat model of traumatic brain injury: possible link between traumatic brain injury and sporadic tauopathies

scientific article published on 30 April 2013

Specific targeting of tau oligomers in Htau mice prevents cognitive impairment and tau toxicity following injection with brain-derived tau oligomeric seeds

scientific article published in January 2014

Tau Oligomers Associate with Inflammation in the Brain and Retina of Tauopathy Mice and in Neurodegenerative Diseases.

scientific article published on October 2016

Tau Oligomers Derived from Traumatic Brain Injury Cause Cognitive Impairment and Accelerate Onset of Pathology in Htau Mice

scientific article published on 5 January 2016

Tau Oligomers: Cytotoxicity, Propagation, and Mitochondrial Damage.

scientific article published on 04 April 2017

Tau Oligomers: The Toxic Player at Synapses in Alzheimer's Disease

scientific article

Tau immunotherapy modulates both pathological tau and upstream amyloid pathology in an Alzheimer's disease mouse model.

scientific article published in March 2015

Tau oligomers as potential targets for immunotherapy for Alzheimer's disease and tauopathies.

scientific article published on September 2011

Tau oligomers impair memory and induce synaptic and mitochondrial dysfunction in wild-type mice.

scientific article published on 6 June 2011

The formation of tau pore-like structures is prevalent and cell specific: possible implications for the disease phenotypes

scientific article

Therapeutic approaches against common structural features of toxic oligomers shared by multiple amyloidogenic proteins.

scientific article published on 07 January 2014

α-Synuclein Oligomers Induce a Unique Toxic Tau Strain.

scientific article published on 17 January 2018